473 results on '"Marcelino J"'
Search Results
452. What do tiger-fly larvae (Diptera: Muscidae) eat?
- Author
-
Santos S, Martins J, Marcelino J, Mateus C, and Figueiredo E
- Subjects
- Animals, Diptera growth & development, Feeding Behavior, Larva growth & development, Oligochaeta parasitology, Predatory Behavior, Diptera physiology, Larva physiology
- Abstract
Coenosia attenuata, usually known as tiger-fly, is a generalist predator of agricultural and forest pests in both larval and adult stages; it has potential to be an effective biocontrol agent in protected crops. To contribute for the knowledge of which prey this predator larvae potentially consumes, and of the occurrence and the conditions that promote cannibalism by tiger-fly larvae, intact alive specimens and portions of the earthworm Lumbricus terrestris were tested as prey and the cannibalism was evaluated in the presence or in absence of fungus gnat larvae. The tiger-fly larvae fed on the bisected earthworm portions but seem to have difficulty to penetrate in the cuticle of the alive and moving L. terrestris. However, the time to start feeding on the portions of L terrestris was shorter than on fungus gnats. Cannibalism by C. attenuato was not detected, but mortality occurred in several modalities. Nevertheless, escaping from the Petri dishes was the dominant behaviour of the larvae in the cannibalism evaluation assay.
- Published
- 2013
453. Critical paths in a metapopulation model of H1N1: Efficiently delaying influenza spreading through flight cancellation.
- Author
-
Marcelino J and Kaiser M
- Abstract
Disease spreading through human travel networks has been a topic of great interest in recent years, as witnessed during outbreaks of influenza A (H1N1) or SARS pandemics. One way to stop spreading over the airline network are travel restrictions for major airports or network hubs based on the total number of passengers of an airport. Here, we test alternative strategies using edge removal, cancelling targeted flight connections rather than restricting traffic for network hubs, for controlling spreading over the airline network. We employ a SEIR metapopulation model that takes into account the population of cities, simulates infection within cities and across the network of the top 500 airports, and tests different flight cancellation methods for limiting the course of infection. The time required to spread an infection globally, as simulated by a stochastic global spreading model was used to rank the candidate control strategies. The model includes both local spreading dynamics at the level of populations and long-range connectivity obtained from real global airline travel data. Simulated spreading in this network showed that spreading infected 37% less individuals after cancelling a quarter of flight connections between cities, as selected by betweenness centrality. The alternative strategy of closing down whole airports causing the same number of cancelled connections only reduced infections by 18%. In conclusion, selecting highly ranked single connections between cities for cancellation was more effective, resulting in fewer individuals infected with influenza, compared to shutting down whole airports. It is also a more efficient strategy, affecting fewer passengers while producing the same reduction in infections.
- Published
- 2012
- Full Text
- View/download PDF
454. Reducing in fl uenza spreading over the airline network.
- Author
-
Marcelino J and Kaiser M
- Abstract
Disease spreading through human travel networks has been a topic of great interest in recent years, such as with swine in fl uenza or SARS pandemics. Most studies have proposed removing highly connected nodes (hubs) to control spreading. Here, we test alternative strategies using edge removal ( fl ight cancellation) for spreading over the airline network. Flight cancellation was more ef fi cient than shutting down whole airports: spreading took 81% longer if solely selected fl ights were removed, compared to a 52% reduction when entire airports were shutdown, affecting the same number of fl ights.
- Published
- 2009
- Full Text
- View/download PDF
455. Colletotrichum acutatum var. fioriniae (teleomorph: Glomerella acutata var. fioriniae var. nov.) infection of a scale insect.
- Author
-
Marcelino J, Giordano R, Gouli S, Gouli V, Parker BL, Skinner M, TeBeest D, and Cesnik R
- Subjects
- Animals, Colletotrichum cytology, Colletotrichum genetics, Connecticut epidemiology, DNA, Fungal chemistry, DNA, Fungal genetics, DNA, Ribosomal chemistry, DNA, Ribosomal genetics, DNA, Ribosomal Spacer chemistry, DNA, Ribosomal Spacer genetics, Fungal Proteins genetics, Genes, Mating Type, Fungal, Genes, rRNA, Molecular Sequence Data, New Jersey epidemiology, New York epidemiology, Pennsylvania epidemiology, Phylogeny, RNA, Fungal genetics, RNA, Ribosomal genetics, Recombination, Genetic, Sequence Analysis, DNA, Tubulin genetics, Colletotrichum isolation & purification, Hemiptera microbiology, Mycoses epidemiology, Mycoses microbiology
- Abstract
An epizootic has been reported in Fiorinia externa populations in New York, Connecticut, Pennsylvania and NewJersey. Infected insects have profuse sclerotial masses enclosing their bodies. The most commonly isolated microorganism from infected F. externa was Colletotrichum sp. A morphological and molecular characterization of this fungus indicated that it is closely related to phytopathogenic C. acutatum isolates. Isolates of Colletotrichum sp. from F. externa in areas of the epizootic were similar genetically and were named Colletotrichum acutatum var. fioriniae var. nov, based on our findings. In vitro and in planta mating observed between isolates of C. acutatum var. fioriniae could serve as a possible source of genetic variation and might give rise to new biotypes with a propensity to infect insects. Only one other strain, C. gloeosporioides f. sp. ortheziidae, has been reported to show entomopathogenic activity.
- Published
- 2008
- Full Text
- View/download PDF
456. Assessing the effects of surfactants on the physical properties of liposome membranes.
- Author
-
Marcelino J, Lima JL, Reis S, and Matos C
- Subjects
- Liposomes, Membranes, Artificial, Surface-Active Agents pharmacology
- Abstract
Knowledge of the partition process of environmentally significant molecules between biological membranes and their surroundings is of vital importance to explain their activity and toxicity, as well as phenomena like absorption, distribution and metabolism. In this research effort, we have studied membrane interactions of three surfactants: t-octylphenoxypolyethoxyethanol (Triton X-100), cetyltrimethylammonium chloride (CTAC) and dodecylbenzene sulphonate (SDBS). Unilamellar liposomes (LUVs) of egg yolk phosphatidylcholine (EPC) were used as membrane models. The partition coefficient, a fundamental parameter in assessing the behaviour of xenobiotic compounds, was determined for SDBS and Triton X-100 by derivative spectrophotometry and fluorescence quenching. The effect of these surfactants upon the physico-chemical characteristics (fluidity, diameter and surface charge) of the liposome membrane was also determined. Results show that all the three surfactants cause an increase in fluidity of the liposome membrane, although for low surfactant concentrations uncharacteristic membrane rigidity was observed, probably due to a change in lipid packing density.
- Published
- 2007
- Full Text
- View/download PDF
457. Consequences of disease-causing mutations on lubricin protein synthesis, secretion, and post-translational processing.
- Author
-
Rhee DK, Marcelino J, Al-Mayouf S, Schelling DK, Bartels CF, Cui Y, Laxer R, Goldbach-Mansky R, and Warman ML
- Subjects
- Amino Acid Motifs, Animals, Antibodies metabolism, COS Cells, Chlorocebus aethiops, Disulfides chemistry, Epitopes, Humans, Joint Diseases metabolism, Joint Diseases pathology, Protein Structure, Tertiary, Syndrome, Synovial Fluid chemistry, Glycoproteins genetics, Glycoproteins metabolism, Joint Diseases genetics, Mutation, Protein Processing, Post-Translational
- Abstract
Lubricin, a protein product of the gene PRG4, is a secreted mucin-like proteoglycan that is a major lubricant in articulating joints. Mutations in PRG4 cause the autosomal recessive, human disorder camptodactyly-arthropathy-coxa vara-pericarditis syndrome. We developed rabbit polyclonal antibodies against human lubricin to determine the consequence of disease-causing mutations at the protein level and to study the protein's normal post-translational processing. Antiserum generated against an epitope in the amino-terminal portion of lubricin detected protein in wild-type synovial fluid and in conditioned media from wild-type cultured synoviocytes. However, the antiserum did not detect lubricin in synovial fluid or cultured synoviocytes from several patients with frameshift or nonsense mutations in PRG4. Antiserum generated against an epitope in the protein's carboxyl-terminal, hemopexin-like domain identified a post-translational cleavage event in wild-type lubricin, mediated by a subtilisin-like proprotein convertase (SPC). Interestingly, in contrast to wild-type lubricin, one disease-causing mutation that removes the last 8 amino acids of the protein, including a conserved cysteine residue, was not cleaved within the hemopexin-like domain when expressed in COS-7 cells. This suggests that formation of an intrachain disulfide bond is required for SPC-mediated cleavage and that SPC-mediated cleavage is essential to protein function.
- Published
- 2005
- Full Text
- View/download PDF
458. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth.
- Author
-
Rhee DK, Marcelino J, Baker M, Gong Y, Smits P, Lefebvre V, Jay GD, Stewart M, Wang H, Warman ML, and Carpten JD
- Subjects
- Animals, Cartilage cytology, Cell Adhesion, Cell Proliferation, Cells, Cultured, Chondrocytes cytology, Chondrocytes metabolism, Hindlimb diagnostic imaging, Hindlimb pathology, Humans, In Situ Hybridization, Joint Diseases genetics, Joint Diseases metabolism, Joint Diseases pathology, Mice, Mice, Knockout, Phenotype, Protein Structure, Secondary, Proteoglycans chemistry, Proteoglycans genetics, Radiography, Recombinant Proteins genetics, Recombinant Proteins metabolism, Surface Properties, Syndrome, Synovial Fluid, Synovial Membrane metabolism, Cartilage metabolism, Joints cytology, Joints growth & development, Joints metabolism, Joints pathology, Proteoglycans metabolism, Synovial Membrane cytology
- Abstract
The long-term integrity of an articulating joint is dependent upon the nourishment of its cartilage component and the protection of the cartilage surface from friction-induced wear. Loss-of-function mutations in lubricin (a secreted glycoprotein encoded by the gene PRG4) cause the human autosomal recessive disorder camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP). A major feature of CACP is precocious joint failure. In order to delineate the mechanism by which lubricin protects joints, we studied the expression of Prg4 mRNA during mouse joint development, and we created lubricin-mutant mice. Prg4 began to be expressed in surface chondrocytes and synoviocytes after joint cavitation had occurred and remained strongly expressed by these cells postnatally. Mice lacking lubricin were viable and fertile. In the newborn period, their joints appeared normal. As the mice aged, we observed abnormal protein deposits on the cartilage surface and disappearance of underlying superficial zone chondrocytes. In addition to cartilage surface changes and subsequent cartilage deterioration, intimal cells in the synovium surrounding the joint space became hyperplastic, which further contributed to joint failure. Purified or recombinant lubricin inhibited the growth of these synoviocytes in vitro. Tendon and tendon sheath involvement was present in the ankle joints, where morphologic changes and abnormal calcification of these structures were observed. We conclude that lubricin has multiple functions in articulating joints and tendons that include the protection of surfaces and the control of synovial cell growth.
- Published
- 2005
- Full Text
- View/download PDF
459. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.
- Author
-
Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Jüppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, and Warman ML
- Subjects
- Adaptor Proteins, Signal Transducing, Adult, Animals, Animals, Outbred Strains, Bone Morphogenetic Protein 2, Bone Morphogenetic Proteins pharmacology, COS Cells, Child, Child, Preschool, Chlorocebus aethiops, Chromosomes, Human, Pair 11 genetics, Culture Media, Conditioned pharmacology, DNA, Complementary genetics, Dishevelled Proteins, Female, Genes, Recessive, Heterozygote, Humans, LDL-Receptor Related Proteins, Low Density Lipoprotein Receptor-Related Protein-5, Male, Mesoderm cytology, Mice, Mice, Inbred C57BL, Organ Culture Techniques, Phosphoproteins genetics, Phosphoproteins physiology, Proteins genetics, Proteins physiology, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins physiology, Receptors, LDL deficiency, Receptors, LDL genetics, Recombinant Fusion Proteins physiology, Recombinant Proteins, Signal Transduction, Skull cytology, Species Specificity, Stromal Cells cytology, Stromal Cells drug effects, Syndrome, Transfection, Wnt Proteins, Wnt-5a Protein, Wnt2 Protein, Wnt3 Protein, Wnt4 Protein, Bone Density genetics, Eye embryology, Eye Abnormalities genetics, Osteoblasts metabolism, Osteoporosis genetics, Receptors, LDL physiology, Transforming Growth Factor beta, Zebrafish Proteins
- Abstract
In humans, low peak bone mass is a significant risk factor for osteoporosis. We report that LRP5, encoding the low-density lipoprotein receptor-related protein 5, affects bone mass accrual during growth. Mutations in LRP5 cause the autosomal recessive disorder osteoporosis-pseudoglioma syndrome (OPPG). We find that OPPG carriers have reduced bone mass when compared to age- and gender-matched controls. We demonstrate LRP5 expression by osteoblasts in situ and show that LRP5 can transduce Wnt signaling in vitro via the canonical pathway. We further show that a mutant-secreted form of LRP5 can reduce bone thickness in mouse calvarial explant cultures. These data indicate that Wnt-mediated signaling via LRP5 affects bone accrual during growth and is important for the establishment of peak bone mass.
- Published
- 2001
- Full Text
- View/download PDF
460. Human disease-causing NOG missense mutations: effects on noggin secretion, dimer formation, and bone morphogenetic protein binding.
- Author
-
Marcelino J, Sciortino CM, Romero MF, Ulatowski LM, Ballock RT, Economides AN, Eimon PM, Harland RM, and Warman ML
- Subjects
- Animals, Bone Morphogenetic Proteins antagonists & inhibitors, COS Cells, Carrier Proteins, Chlorocebus aethiops, Dimerization, Disulfides, Female, Humans, Oocytes physiology, Protein Biosynthesis, Recombinant Proteins metabolism, Synostosis genetics, Transfection, Xenopus laevis, Bone Morphogenetic Proteins metabolism, Mutation, Missense, Proteins genetics, Proteins metabolism
- Abstract
Secreted noggin protein regulates bone morphogenetic protein activity during development. In mice, a complete loss of noggin protein leads to multiple malformations including joint fusion, whereas mice heterozygous for Nog loss-of-function mutations are normal. In humans, heterozygous NOG missense mutations have been found in patients with two autosomal dominant disorders of joint development, multiple synostosis syndrome (SYNS1) and a milder disorder proximal symphalangism (SYM1). This study investigated the effect of one SYNS1 and two SYM1 disease-causing missense mutations on the structure and function of noggin. The SYNS1 mutation abolished, and the SYM1 mutations reduced, the secretion of functional noggin dimers in transiently transfected COS-7 cells. Coexpression of mutant noggin with wild-type noggin, to resemble the heterozygous state, did not interfere with wild-type noggin secretion. These data indicate that the human disease-causing mutations are hypomorphic alleles that reduce secretion of functional dimeric noggin. Therefore, we conclude that noggin has both species-specific and joint-specific dosage-dependent roles during joint formation. Surprisingly, in contrast to the COS-7 cell studies, the SYNS1 mutant was able to form dimers in Xenopus laevis oocytes. This finding indicates that there also exist species-specific differences in the ability to process mutant noggin polypeptides.
- Published
- 2001
- Full Text
- View/download PDF
461. Production and characterization of a mouse monoclonal antibody against the Gag p26 protein of human immunodeficiency virus type 2: identification of a new antigenic epitope.
- Author
-
Marcelino JM, Novo C, Pereira JM, Picotez F, Clemente A, and Taveira N
- Subjects
- Amino Acid Sequence, Animals, Antibodies, Monoclonal genetics, Antibody Specificity, Blotting, Western, Enzyme-Linked Immunosorbent Assay, Epitope Mapping, Epitopes chemistry, Gene Products, gag chemistry, HIV Antibodies biosynthesis, HIV Antibodies genetics, HIV Antigens chemistry, HIV-1 immunology, Humans, Mice, Mice, Inbred BALB C, Molecular Sequence Data, gag Gene Products, Human Immunodeficiency Virus, Antibodies, Monoclonal biosynthesis, Antibodies, Monoclonal immunology, Epitopes immunology, Gene Products, gag immunology, HIV Antibodies immunology, HIV Antigens immunology, HIV-2 immunology
- Abstract
One anticapsid (p26) mouse monoclonal antibody was developed after immunization with recombinant p26 Gag protein and was tested for reactivity with different HIV-1 and HIV-2 isolates by ELISA and Western blot analysis. This antibody, named R26.1, reacted with all HIV-2 isolates tested and with recombinant p26 proteins, but no HIV-1 isolates. The epitope of antibody R26.1 was mapped to residues 50-71 in the N-terminal domain of the capsid protein, a highly conserved region in all HIV-2 isolates sequenced to date. This monoclonal antibody may be useful for the detection of HIV-2, and for the discrimination between HIV-1 and HIV-2 infections. Likewise, the identified epitope may be useful for the detection of p26 antibodies in HIV-2-infected individuals.
- Published
- 2001
- Full Text
- View/download PDF
462. Neutralization of crotaline snake venoms from Central and South America by antivenoms produced in Brazil and Costa Rica.
- Author
-
Bogarín G, Morais JF, Yamaguchi IK, Stephano MA, Marcelino JR, Nishikawa AK, Guidolin R, Rojas G, Higashi HG, and Gutiérrez JM
- Subjects
- Animals, Antivenins administration & dosage, Blood Coagulation drug effects, Blood Coagulation physiology, Blood Coagulation Tests, Brazil, Coagulants antagonists & inhibitors, Costa Rica, Cross Reactions, Crotalid Venoms toxicity, Hemolysis drug effects, Hemorrhage prevention & control, In Vitro Techniques, Injections, Intraperitoneal, Lethal Dose 50, Mice, Neutralization Tests, Antivenins pharmacology, Crotalid Venoms antagonists & inhibitors
- Abstract
A study was performed on the ability of antivenoms, produced in Brazil and Costa Rica, to neutralize lethal, hemorrhagic and coagulant activities of the venoms of 16 species of Central and South American snakes of the subfamily Crotalinae. Neutralization of lethality was studied by two different methods routinely used in the quality control of antivenoms at Instituto Butantan (IB) and Instituto Clodomiro Picado (ICP). Both antivenoms neutralized the majority of the venoms studied, but the values of effective doses 50% (ED(50)) differed markedly depending on the method used. In general, higher potencies were obtained with the method of ICP, where a challenge dose corresponding to 4 LD(50)s is used, than with the method of IB, where a challenge dose of 5 LD(50)s is employed. All venoms induced hemorrhagic activity in the mouse skin test, which was effectively neutralized by the two antivenoms. All venoms, except those of Porthidium nasutum and Bothriechis lateralis, induced coagulation of human plasma in vitro and both antivenoms were effective in the neutralization of this activity. In conclusion, our results provide evidence of an extensive cross reactivity between these antivenoms and Central and South American crotaline snake venoms.
- Published
- 2000
- Full Text
- View/download PDF
463. CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome.
- Author
-
Marcelino J, Carpten JD, Suwairi WM, Gutierrez OM, Schwartz S, Robbins C, Sood R, Makalowska I, Baxevanis A, Johnstone B, Laxer RM, Zemel L, Kim CA, Herd JK, Ihle J, Williams C, Johnson M, Raman V, Alonso LG, Brunoni D, Gerstein A, Papadopoulos N, Bahabri SA, Trent JM, and Warman ML
- Subjects
- Amino Acid Sequence, Animals, Base Sequence, Cattle, DNA Mutational Analysis, Female, Genotype, Humans, Hyperplasia genetics, Hyperplasia pathology, Joint Diseases pathology, Male, Molecular Sequence Data, Mutation, Pericarditis pathology, Phenotype, Proteoglycans chemistry, RNA, Messenger analysis, RNA, Messenger genetics, Sequence Homology, Amino Acid, Syndrome, Synovial Membrane metabolism, Synovial Membrane pathology, Joint Diseases genetics, Pericarditis genetics, Proteoglycans genetics, Proteoglycans metabolism
- Abstract
Altered growth and function of synoviocytes, the intimal cells which line joint cavities and tendon sheaths, occur in a number of skeletal diseases. Hyperplasia of synoviocytes is found in both rheumatoid arthritis and osteoarthritis, despite differences in the underlying aetiologies of the two disorders. We have studied the autosomal recessive disorder camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP; MIM 208250) to identify biological pathways that lead to synoviocyte hyperplasia, the principal pathological feature of this syndrome. Using a positional-candidate approach, we identified mutations in a gene (CACP) encoding a secreted proteoglycan as the cause of CACP. The CACP protein, which has previously been identified as both 'megakaryocyte stimulating factor precursor' and 'superficial zone protein', contains domains that have homology to somatomedin B, heparin-binding proteins, mucins and haemopexins. In addition to expression in joint synovium and cartilage, CACP is expressed in non-skeletal tissues including liver and pericardium. The similarity of CACP sequence to that of other protein families and the expression of CACP in non-skeletal tissues suggest it may have diverse biological activities.
- Published
- 1999
- Full Text
- View/download PDF
464. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis.
- Author
-
Gong Y, Krakow D, Marcelino J, Wilkin D, Chitayat D, Babul-Hirji R, Hudgins L, Cremers CW, Cremers FP, Brunner HG, Reinker K, Rimoin DL, Cohn DH, Goodman FR, Reardon W, Patton M, Francomano CA, and Warman ML
- Subjects
- Adolescent, Animals, Carrier Proteins, Cats, Chickens, Chromosome Mapping, Female, Finger Joint abnormalities, Gene Expression Regulation, Developmental, Genetic Markers, Gorilla gorilla, Heterozygote, Humans, Joints physiology, Male, Mice, Molecular Sequence Data, Morphogenesis, Sequence Analysis, Sequence Homology, Amino Acid, Sequence Homology, Nucleic Acid, Swine, Xenopus laevis, Zebrafish, Abnormalities, Multiple genetics, Joints abnormalities, Mutation, Proteins genetics, Synostosis genetics
- Abstract
The secreted polypeptide noggin (encoded by the Nog gene) binds and inactivates members of the transforming growth factor beta superfamily of signalling proteins (TGFbeta-FMs), such as BMP4 (ref. 1). By diffusing through extracellular matrices more efficiently than TGFbeta-FMs, noggin may have a principal role in creating morphogenic gradients. During mouse embryogenesis, Nog is expressed at multiple sites, including developing bones. Nog-/- mice die at birth from multiple defects that include bony fusion of the appendicular skeleton. We have identified five dominant human NOG mutations in unrelated families segregating proximal symphalangism (SYM1; OMIM 185800) and a de novo mutation in a patient with unaffected parents. We also found a dominant NOG mutation in a family segregating multiple synostoses syndrome (SYNS1; OMIM 186500); both SYM1 and SYNS1 have multiple joint fusion as their principal feature. All seven NOG mutations alter evolutionarily conserved amino acid residues. The findings reported here confirm that NOG is essential for joint formation and suggest that NOG requirements during skeletogenesis differ between species and between specific skeletal elements within species.
- Published
- 1999
- Full Text
- View/download PDF
465. [Enormous lingual lymphangioma].
- Author
-
Beziat JL, Marcelino JP, Abou-Chebel N, Vitrey D, and Caschera G
- Subjects
- Aged, Disease Progression, Female, Follow-Up Studies, Glossectomy, Humans, Lymphangioma surgery, Macroglossia pathology, Macroglossia surgery, Tongue Neoplasms surgery, Treatment Outcome, Lymphangioma pathology, Tongue Neoplasms pathology
- Abstract
The authors report a huge lymphangioma of the tongue in a sixty-seven years old female patient. The remarkable progression in dimensions of this lesion, leading to the inevitable protrusion of the tongue, led to the realization of an extended glossectomy, with a functional objective in mind. This simple procedure showed an excellent five years follow-up results. From this case report, the authors stress up on the etiopathogenic, pathological, clinical as well as therapeutic aspects of lingual lymphangioma.
- Published
- 1997
466. Central vascular malformation of the mandible: a case report.
- Author
-
Beziat JL, Marcelino JP, Bascoulergue Y, and Vitrey D
- Subjects
- Adolescent, Arteriovenous Malformations therapy, Embolization, Therapeutic, Face blood supply, Female, Hemangioma, Cavernous surgery, Humans, Mandibular Neoplasms etiology, Mandibular Neoplasms surgery, Neovascularization, Pathologic, Arteriovenous Malformations complications, Hemangioma, Cavernous blood supply, Hemangioma, Cavernous etiology, Mandible blood supply, Mandibular Neoplasms blood supply, Maxillary Artery abnormalities
- Published
- 1997
- Full Text
- View/download PDF
467. Effect of beta-propiolactone treatment on the complement activation mediated by equine antisera.
- Author
-
Guidolin R, Morais JF, Stephano MA, Marcelino JR, Yamaguchi IK, and Higashi HG
- Subjects
- Animals, Guinea Pigs, Horses, Anti-Infective Agents, Local pharmacology, Complement Activation drug effects, Complement Activation immunology, Immune Sera immunology, Propiolactone pharmacology
- Abstract
Reduction of complement activation through an alteration of the Fc fragment of immunoglobulins by beta-propiolactone treatment was carried out in equine antisera raised against rabies virus, Bothrops venoms and diphtherial toxin. Results were evaluated by means of an anaphylactic test performed on guinea-pigs, and compared to the ones obtained with the same sera purified by saline precipitation (ammonium sulfate), followed or not by enzymatic digestion with pepsin. Protein purity levels for antibothropic serum were 184.5 mg/g and 488.5 mg/g in beta-propiolactone treated and pepsin-digested sera, respectively. The recovery of specific activity was 100% and 62.5% when using antibothropic serum treated by beta-propiolactone and pepsin digestion, respectively. The antidiphtherial and anti-rabies sera treated with beta-propiolactone and pepsin presented protein purity levels of 5,698 and 7,179 Lf/g, 16,233 and 6,784 IU/g, respectively. The recovery of specific activity for these antisera were 88.8%, 77.7%, 100% and 36.5%, respectively. beta-propiolactone treatment induced a reduction in complement activation, tested "in vivo", without significant loss of biological activity. This treatment can be used in the preparation of heterologous immunoglobulins for human use.
- Published
- 1997
- Full Text
- View/download PDF
468. Inadequate treatment with HMG-CoA reductase inhibitors by health care providers.
- Author
-
Marcelino JJ and Feingold KR
- Subjects
- Adult, Aged, Aged, 80 and over, Fatty Acids, Monounsaturated therapeutic use, Female, Fluvastatin, Humans, Indoles therapeutic use, Lovastatin therapeutic use, Male, Middle Aged, Patient Selection, Pravastatin therapeutic use, Retrospective Studies, Treatment Outcome, Anticholesteremic Agents therapeutic use, Cholesterol, LDL blood, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hyperlipidemias blood, Hyperlipidemias drug therapy
- Abstract
Purpose: To determine if patients treated with HMG-CoA reductase inhibitors have their LDL cholesterol levels at or below the levels recommended by the National Cholesterol Education Program (NCEP) and if patients on these medications are monitored for potential toxicity., Patients and Methods: Ninety patients from the VA Medical Center in San Francisco were randomly selected in this retrospective analysis. All patients were taking a HMG-CoA reductase inhibitor as monotherapy for treatment of high blood cholesterol for a minimum of 1 year. Medical charts and laboratory and pharmacy computer databases were utilized to gather information regarding the patients' medical history, treatment history, relevant laboratory tests, and medication refill profile., Results: The majority of patients, 73%, were secondary prevention patients. Only 33% of the 90 subjects met the LDL cholesterol goal recommended by the NCEP. For the secondary prevention patients, only 24% met goal LDL. Even when the stringency of the NCEP guidelines was reduced by 20% (goal LDL < 120 mg/dL), 50% of the secondary prevention patients were still inadequately treated. Only 2 of the 90 patients were on maximal dosage regimens. Sixty-seven percent of patients had annual lipid panels and 49% had annual liver panels. Forty-five percent of patients followed by nonphysicians met goal LDL while only 29% and 31% of patients followed by attending physicians and residents/fellows met goal LDL, respectively. In addition, patients followed by nonphysicians were monitored more closely for efficacy and toxicity of the medications., Conclusions: Based on the current NCEP recommendations, patients on monotherapy with HMG-CoA reductase inhibitors are often inadequately treated. Only 33% of the patients evaluated at our institution were at or below the NCEP recommended LDL cholesterol levels and less than half of the patients were adequately monitored for hepatotoxicity.
- Published
- 1996
- Full Text
- View/download PDF
469. Antigenic cross-reactivity among components of Brazilian Elapidae snake venoms.
- Author
-
Higashi HG, Guidolin R, Caricati CP, Fernandes I, Marcelino JR, Morais JF, Yamagushi IK, Stephano MA, Dias-da-Silva W, and Takehara HA
- Subjects
- Animals, Brazil, Cross Reactions, Horses, Lethal Dose 50, Antivenins biosynthesis, Elapid Venoms immunology
- Abstract
Snake venoms from M. corallinus (LD50 = 7.1 +/- 0.83 micrograms), M. frontalis (LD50 = 19.3 +/- 3.13 micrograms), M. ibiboboca (LD50 = 19.8 +/- 2.07 micrograms) and M. spiixi (LD50 = 6.7 +/- 1.25 micrograms) (family Elapidae, genus Micrurus) injected into horses alone or in combination (M. corallinus with M. frontalis) elicit antibody production, as indicated in vivo by neutralization of venom lethality and in vitro by enzyme-linked immunosorbent assay (ELISA), immunoelectrophoresis (IE) and Western blotting (WB). Venom lethality was efficiently neutralized by the antisera, with the monovalent antivenoms being more efficient than the bivalent antivenom. Antibodies against venom components were detected by all antisera at different titers by ELISA. Upon IE, antisera against M. spiixi and M. frontalis venoms cross-reacted with the four types of venoms studied and recognized several molecular components, the precipitin lines obtained had distinct intensities and electrophoretic motilities, whereas the antivenom against M. corallinus only recognized components of its venom but not of the others. All antivenoms cross-reacted with all the elapid venoms in WB revealing several bands with distinct MWs in M. corallinus and M. spiixi venoms, two very sharp and separate bands in M. corallinus venom and a very sharp band of high MW together with several other smaller and faint bands in M. frontalis venom. The data indicate that snake venoms of the genus Micrurus are good immunogens that contain many cross-reactive molecules, and that their toxic components are neutralized more effectively by monovalent rather than by bivalent antivenom.
- Published
- 1995
470. Attachment of articular cartilage chondrocytes to the tissue form of type VI collagen.
- Author
-
Marcelino J and McDevitt CA
- Subjects
- Amino Acid Sequence, Animals, Cations, Divalent pharmacology, Cattle, Cell Adhesion drug effects, Cells, Cultured, Collagen isolation & purification, Electrophoresis, Agar Gel, Electrophoresis, Polyacrylamide Gel, Molecular Sequence Data, Oligopeptides pharmacology, Pepsin A, Cartilage, Articular metabolism, Collagen metabolism
- Abstract
Type VI collagen is composed of a short triple helix rich in RGD sequences with globular domains at each extremity of the helix. Disulfide-bonded tetramers of the monomeric molecule associate non-covalently to form networks of microfibrils in connective tissues, including cartilage. The disulfide-bonded tetramer can be extracted with 6 M guanidine HCl and purified without pepsin digestion and is referred to here as the tissue form of type VI collagen. Type VI collagen in mature articular cartilage appears to be concentrated pericellularly. We undertook a systematic investigation using solid phase assays to establish the nature of the attachment of bovine articular cartilage chondrocytes to the intact, tissue form of bovine type VI collagen. The tissue form of type VI collagen was extracted from bovine meniscus cartilage with 6 M guanidine HCl and purified by polyethylene glycol precipitation. When equal molar quantities were coated on microwells, the tissue form of type VI collagen attached more cells than the pepsin-digested form of the molecule that lacked the globular domains. The attachment to the intact, tissue form was dose-dependent and saturable and was not inhibited by heparin or type II collagen. A linear GRGDSP peptide failed to inhibit attachment of the chondrocytes to the intact, tissue or pepsin-digested forms of type VI collagen, but totally inhibited the interaction when the intact molecule was reduced and alkylated. In contrast, a cyclic C*GRGDSPC* peptide inhibited attachment to the tissue form of type VI collagen, but not to fibronectin. The attachment had a metal ion dependence that could be satisfied by MnCl2, slightly less by MgCl2, but not at all by CaCl2. A direct interaction between the tissue form of type VI collagen and a chondrocyte cell surface receptor or receptors is a structural feature of the pericellular matrix in cartilage.
- Published
- 1995
- Full Text
- View/download PDF
471. [Wilson-Jones tumors of proliferating tricholemmal cysts. Apropos of 2 cases].
- Author
-
Tchatirian E, Vitrey D, Marcelino JP, and Béziat JL
- Subjects
- Aged, Carcinoma, Squamous Cell pathology, Diagnosis, Differential, Female, Follow-Up Studies, Humans, Middle Aged, Scalp pathology, Skin Neoplasms pathology, Epidermal Cyst pathology, Scalp Dermatoses pathology
- Abstract
The authors report two new cases of proliferating tricholemmal cyst. Physiopathological, clinical and histological findings are described. Differential diagnosis with squamous cell carcinoma is discussed.
- Published
- 1995
472. [Condylar osteochondroma: apropos of 3 cases with arthritic lesions].
- Author
-
Beziat JL, Marcelino JP, Vitrey D, and Perez-Ortiz N
- Subjects
- Adult, Arthritis etiology, Female, Humans, Mandibular Neoplasms complications, Osteochondroma complications, Temporomandibular Joint Disorders etiology, Arthritis pathology, Mandibular Condyle pathology, Mandibular Neoplasms pathology, Osteochondroma pathology, Temporomandibular Joint Disorders pathology
- Abstract
Three cases of osteochondroma of the mandibular condyle were observed with arthrosis type lesions. Based on a review of the literature, the epidemiologic, symptomatologic, pathologic and diagnostic characteristics of this rare benign tumour with facial localization are presented together with the therapeutic approach.
- Published
- 1994
473. Interaction of intact type VI collagen with hyaluronan.
- Author
-
McDevitt CA, Marcelino J, and Tucker L
- Subjects
- Animals, Binding, Competitive, Blotting, Western, Cartilage chemistry, Cattle, Chemical Precipitation, Collagen isolation & purification, Enzyme-Linked Immunosorbent Assay, Humans, Hyaluronoglucosaminidase metabolism, Male, Polyethylene Glycols, Testis enzymology, Collagen metabolism, Hyaluronic Acid metabolism
- Abstract
The capacity of non-pepsinyzed type VI collagen to bind to hyaluronan was investigated. Type VI collagen was extracted from bovine meniscal cartilage with 6 M GuHCl and purified by extraction of PEG precipitates and dissociative Sephacryl S-500 HR chromatography. Type VI collagen, detected with a monoclonal antibody, bound in 0.5 M NaCl to hyaluronan-coated micro-wells, the degree of binding being higher at 37 degrees C than 23 degrees C and 4 degrees C. Incubation of type VI collagen in competitive inhibition assays with testicular hyaluronidase digests of hyaluronan in liquid phase, reduced binding of the protein to hyaluronan-coated microwells to background levels. Thus, non-pepsinyzed type VI collagen binds to hyaluronan in vitro.
- Published
- 1991
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.